US Markets

S&P 500, Dow futures turn positive on COVID-19 vaccine hopes

Credit: REUTERS/BRENDAN MCDERMID

Futures tracking the S&P 500 and Dow indexes pared early declines to trade marginally higher, as hopes of a coronavirus vaccine offset concerns about the economic damage from a surge in domestic COVID-19 infections.

July 20 (Reuters) - Futures tracking the S&P 500 and Dow indexes pared early declines to trade marginally higher, as hopes of a coronavirus vaccine offset concerns about the economic damage from a surge in domestic COVID-19 infections.

German biotech firm BioNTech BNTX.O and U.S. drugmaker Pfizer PFE.N reported additional data from their experimental coronavirus vaccine that showed the vaccine was safe and induced an immune response in patients.

At 9:01 a.m. ET, Dow e-minis 1YMcv1 were up 15 points, or 0.06%, and S&P 500 e-minis EScv1 were up 1.25 points, or 0.04%. Nasdaq 100 e-minis NQcv1, which were up before the report, hit session highs.

(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Shounak Dasgupta)

((Sagarika.Jaisinghani@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2256;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BNTX PFE NDX SPX

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More